Levels of angiogenic peptides in sera from patients with carcinoid tumours during alpha-interferon treatment.

Nilsson, A; Janson, E T; Eriksson, B; Larsson, A

Nilsson, A; Janson, E T; Eriksson, B; Larsson, A.

Affiliation

Nilsson A; Department of Medical Sciences, University Hospital, Uppsala, Sweden.

Anticancer Res ; 21(6A): 4087-90, 2001.

Article in En | MEDLINE | ID: mdl-11911297

Subject(s)

Antineoplastic Agents/therapeutic use; Carcinoid Tumor/blood; Carcinoid Tumor/drug therapy; Endothelial Growth Factors/blood; Fibroblast Growth Factor 2/blood; Interferon-alpha/therapeutic use; Intestinal Neoplasms/blood; Intestinal Neoplasms/drug therapy; Lymphokines/blood; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors/therapeutic use; Carcinoid Tumor/blood supply; Female; Humans; Intestinal Neoplasms/blood supply; Male; Middle Aged; Neovascularization, Pathologic/blood; Neovascularization, Pathologic/drug therapy; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoid Tumor / Endothelial Growth Factors / Fibroblast Growth Factor 2 / Lymphokines / Interferon-alpha / Intestinal Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2001 Document type: Article Affiliation country: Sweden Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links